(Press-News.org) Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer. Researchers have managed to combine three different functions in the antibody, which together strongly amplify the effect of T cells on the cancer tumour. The study has been published in Nature Communications.
Researchers have developed a unique type of antibody that both targets and delivers a drug package via the antibody itself, while simultaneously activating the immune system (“3-in-1 design”) for personalised immunotherapy treatments.
“We have been researching precision medicine for close to 15 years now, as well as how we can use antibodies to influence an important key protein (CD40) in the immune system. We can now show that our new antibody method works as precision medicine for cancer,” explains Sara Mangsbo, professor at the Department of Pharmacy at Uppsala University, who together with Johan Rockberg, professor at KTH Royal Institute of Technology, is the study’s lead author.
The drug redirects the immune system to find and target specific mutations and gene changes that are only found in cancer cells, known as neoantigens. This is achieved by the new antibody both delivering the unique tumour-specific material directly to a particular type of immune cell and by stimulating this cell simultaneously, which then has the capacity to greatly enhance the T-cell response to the tumour.
The results show that the method works in several ways. Not only does it activate the right type of immune cells in human blood samples, but animal models show that mice receiving the treatment had prolonged survival and, at higher doses, also save the mice from cancer, and that the method is safer than previous cancer treatments the researchers have studied.
Customised precision medicines can be both costly and time-consuming to develop.
“The advantage of our drug is that it is easy to produce on a larger scale , yet can be easily tailored to the patient’s disease or specific tumour. The medicine consists of two parts that are combined, a targeting bispecific antibody – which can be produced in large quantities in advance – and a custom peptide part, which is produced rapidly synthetically on a small scale for a desired type of cancer. Both in terms of production cost and the short time it takes to tailor a peptide to a new tumour, this increases availability and should make it quicker for patients to go from diagnosis to treatment,” explains Johan Rockberg, Professor at KTH Royal Institute of Technology.
The aim of the study was to establish a more flexible, faster and safer treatment for cancer than those currently available. The study has already shown that the method has the potential to be customised for each patient, thereby strengthening the immune system against cancer. The next step is to use the fully optimised production process to manufacture the drug candidate for further safety studies and then start clinical trials in humans.
END
New antibody could be promising cancer treatment
2024-11-11
ELSE PRESS RELEASES FROM THIS DATE:
The public implications of private substitutes for electric grid reliability
2024-11-11
Climate change events have, in recent years, placed increasing strain on public electrical grids in the United States. In response to this vulnerability, some consumers are turning to private alternatives to the electric utility, like generators and batteries. A new paper in the Journal of the Association of Environmental and Resource Economists studies who adopts these private alternatives and how adoption responds to grid failures. The paper also studies how public electric grid reliability may change due to this proliferation and how these changes will affect the wellbeing of all households.
In ...
Religiosity, spirituality, and meaning-making generally associated with lower suicidality
2024-11-11
November 11, 2024 — All aspects of religiosity, spirituality, and meaning-making (R/S/M) relate to suicidality in people with a psychiatric diagnosis or a recent suicide attempt, according to a systematic review and meta-analysis published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer.
"Protective dimensions seemed to exert relatively stable effects across different religions and life views," Bart van den Brink, MD, PhD, of the Department of ...
Eife studying legal surveillance as social determinant of health
2024-11-11
Erin Eife, Assistant Professor, Criminology, Law and Society, College of Humanities and Social Sciences (CHSS), received funding for the project: “Surveillance as a Social Determinant of Health: Understanding the Impact of Pending Charges on Health Outcomes.”
Eife will conduct this research under the advisement of Evan Lowder, Associate Professor, Criminology, Law and Society, College of Humanities and Social Sciences (CHSS), and Lauren Brinkley-Rubinstein, Associate Professor in the Department of Population Health Sciences at Duke University.
Eife aims to produce knowledge about ...
Newly developed 100Gbps data transfer system for accelerating Open Science through industry-university collaboration in Japan
2024-11-11
Tokyo & Osaka, Japan – Osaka University and NEC Corporation (NEC; TSE: 6701) are moving forward with efforts to realize a data infrastructure supporting Open Science. In 2021, The Joint Research Laboratory for Integrated Infrastructure of High Performance Computing and Data Analysis was established within the D3 Center, Osaka University (Director: Professor Susumu Date*1) by Osaka University and NEC. The result of the Joint Research Laboratory will be showcased at the International Conference for High Performance Computing, Networking, Storage, and Analysis (SC24) scheduled ...
Navigating bias in AI-driven cancer detection
2024-11-11
“As we eagerly adopt Al models, we need to take a moment to think about the potential biases that they may contain.”
BUFFALO, NY - November 11, 2024 – A new editorial was published in Oncotarget's Volume 15 on November 7, 2024, titled “ Beyond the hype: Navigating bias in AI-driven cancer detection.”
In this editorial, researchers from the Mayo Clinic emphasize the need to address potential biases in Artificial Intelligence (AI) tools used for cancer detection to ensure fair and equitable healthcare. Authors Yashbir Singh, Heenaben Patel, Diana V. Vera-Garcia, Quincy A. Hathaway, ...
Research shows stress about personal finances may make leaders abusive in workplace
2024-11-11
New research from Colorado State University shows that workplace leaders who are financially stressed are more likely to be abusive toward their subordinates – particularly if the leader is a man.
The findings, published in the Journal of Occupational Health Psychology, provide insight into leader behavior due to a common source of stress. The research was led by Assistant Professor Keaton Fletcher in the Department of Psychology in partnership with Associate Professor Trevor Spoelma in the Anderson School of Management at the University ...
Holistic approach of nutrients and traditional natural medicines for human health
2024-11-11
In recent years, there has been a rising interest in combining traditional natural medicines with essential nutrients to foster a holistic approach to human health. The focus on integrating both elements reflects an understanding of health that transcends the simple absence of disease, encompassing physical, mental, and spiritual well-being. This review highlights how traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine (TCM), and other indigenous practices worldwide, can be harmonized with nutritional science to form a comprehensive healthcare approach. Such a combination has the potential to improve disease prevention and enhance overall ...
Study: Online E-cigarette retailers fail to comply with sale regulations
2024-11-11
Online e-cigarette retailers are not consistently adhering to laws aimed at preventing the sale of vaping products to minors, including regulations on age verification, shipping methods and flavor restrictions, report researchers at the Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego.
In a study published online on Nov. 11, 2024 in JAMA, researchers asked 16 people to purchase flavored vape products online and have them delivered to their homes in the County of San Diego, ...
Prevalence of adverse childhood experiences in child population samples
2024-11-11
About The Study: In this study, adverse childhood experiences (ACEs), which include abuse, neglect, and family dysfunction, were prevalent among children with notable disparities across participant demographic characteristics and contexts. As principal antecedent threats to child and adolescent well-being that can affect later life prospects, ACEs represent a pressing global social issue. Effective early identification and prevention strategies, including targeted co-designed community interventions, can reduce the prevalence of ACEs and mitigate their severe effects, thereby minimizing the harmful health consequences of childhood adversity in future generations.
Corresponding ...
Asthma and memory function in children
2024-11-11
About The Study: In this cohort study, asthma was associated with memory difficulties in children, which may be more severe if asthma onset is earlier in childhood and may extend to executive function abilities.
Corresponding Author: To contact the corresponding author, Nicholas J. Christopher-Hayes, MA, email nchristopherhayes@ucdavis.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.42803)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of ...